This study recommends implementing multidimensional genotype – protein phenotype assessment methods as a pre-laboratory approach in developing personalized medicine for IBD patients carrying NOD2 (R675W and G908R) and IL23R (G149R and R381N) variants. This evidence concerns the gene IL23R and inflammatory bowel disease.